Paul Wender Best Paper in the Journal of Clinical Psychiatry Award

2019 Best Paper in The Journal of Clinical Psychiatry Award Nominations are now closed. Notifications will be sent in February 2019.  


The American Society of Clinical Psychopharmacology (ASCP) presents the Paul Wender Best Paper in The Journal of Clinical Psychiatry Award to a recipient who has been published in the past year (January 2018 to present date) for the Journal of Clinical Psychiatry.

Known as the “Dean of ADHD” by his colleagues, Paul H. Wender, MD, was a pioneer in identifying and treating attention deficit hyperactivity disorder. A researcher and clinician who treated patients with ADHD for many years, he offered insights into the progression of ADHD, as well as dietary, drug, and psychological treatments. He was the author of the classic handbook on the subject, ADHD: Attention-Deficit Hyperactivity Disorder in Children and Adults.

Wender was involved in the study of ADHD for over thirty years and wrote the first monograph on the disorder in 1971 (Minimal Brain Dysfunction in Children). In this monograph, he advanced the hypotheses that the disorder was genetic in origin and was mediated by decreased activity in dopaminergic systems in the brain. Because he found education of the parents of ADHD children played a substantial role in treatment, he described the symptoms, the causes, and the management of children with ADHD in a book published in 1974, The Hyperactive Child. The 4th edition, ADHD in Children and Adults, was published in 2000 and contains information for ADHD adults about how accurate diagnosis can be made and how ADHD in adults is best treated. He and his colleagues discovered that ADHD in adults was a recognizable disorder. They initiated studies of ADHD in adults beginning in 1976 and have conducted extensive research in this area since that time. He wrote the first monograph on ADHD in adults (Attention Deficit Hyperactivity Disorder in Adults) in 1995.

The award consists of a $1,000 stipend and a plaque to be given during the 2019 ASCP Annual Meeting (formerly NCDEU) on May 28-31, 2019 in Scottsdale, Arizona. The Award Winner must attend the ASCP Annual Meeting.

The ASCP Award Committee will review the papers submitted to The Journal of Clinical Psychiatry for the 2018 year. Papers must be original reports or meta-analysis on patient relevant research relevant to clinical psychopharmacology. The top five downloaded papers from 2018 will also be included in the nomination.

Anyone may nominate an individual for this award by submitting the following to the Awards Committee:

  1. Submit name and citation.
  2. A brief paragraph describing why the article should be chosen for the award.

Submissions nominating individuals for this award must be sent to the ASCP Executive Office. Nominations must have been submitted by January 14, 2019. 

Nominations can be sent by email, fax, or postal mail. If sending by email, please send to If sending by fax, the ASCP Fax number is 1-888-417-3311. If sending by postal mail, the submission envelope as well as the material sent must indicate the award for which the submission is made. Please mail to the following address:

ASCP Executive Office
Best Paper Award
5034A Thoroughbred Lane
Brentwood, TN 37027


Congratulations to Philip Gerretsen, MD, FRCPC, recipient of the 2018 Paul Wender Best Paper in The Journal of Clinical Psychiatry Award.